Stock Events

Stock Events

Stereotaxis 

$1.4200
29
+$0.00+0% Monday 19:59
-$0.01-0.7%Monday 22:57After hours

Statistics

Day High
1.42
Day Low
1.41
52W High
3.59
52W Low
1.24
Volume
11,432
Avg. Volume
-
Mkt Cap
142.29M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

5NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-0.09
-0.08
-0.06
-0.05
Expected EPS
-0.053333
Actual EPS
N/A

Financials

-70.77%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
32.38MRevenue
-22.91MNet Income

Analyst Ratings

3.00Average Price Target
The highest estimate is 3.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow STXS. It's not an investment recommendation.
Tesla
6
TSLA
NVIDIA
6
NVDA
Rocket Lab
6
RKLB
Amazon
5
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Intuitive Surgical
ISRG
Mkt Cap133.83B
Intuitive Surgical is a leading developer of robotic-assisted surgical systems, directly competing with Stereotaxis in the robotic surgery space.
Medtronic
MDT
Mkt Cap119.49B
Medtronic offers robotic-assisted surgical solutions and cardiac devices, competing in the same medical device market as Stereotaxis.
Smith & Nephew
SNN
Mkt Cap12.25B
Smith & Nephew provides advanced surgical robotics for orthopedics, competing in the broader field of robotic surgery.
Zimmer Biomet
ZBH
Mkt Cap19.26B
Zimmer Biomet Holdings, Inc. competes in the development of medical devices for musculoskeletal healthcare, including robotic assistance technologies.
Boston Scientific
BSX
Mkt Cap73B
Boston Scientific Corporation offers products in interventional cardiology, competing with Stereotaxis in the cardiac device market.
Abbott Laboratories
ABT
Mkt Cap201.83B
Abbott Laboratories provides a wide range of medical devices, including cardiac and vascular devices, competing with Stereotaxis's offerings.
Johnson & Johnson
JNJ
Mkt Cap651.25B
Johnson & Johnson, through its medical devices segment, competes in the surgical and cardiovascular markets.
Stryker
SYK
Mkt Cap126.37B
Stryker Corporation specializes in medical and surgical equipment, including robotic surgery systems, competing in the same space as Stereotaxis.
Edwards Lifesciences
EW
Mkt Cap51.75B
Edwards Lifesciences specializes in heart valve therapy and critical care, competing in the cardiovascular market with Stereotaxis.

About

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems, Disposables, Royalty, and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.
Show more...
CEO
David L. Fischel
Employees
131
Country
United States
ISIN
US85916J4094
WKN
000A1J09L

Listings

XASE
US
STXS
STU
DE
RJR1.STU
MU
DE
RJR1.MU
F
DE
RJR1.F

0 Comments

Share your thoughts

FAQ

What is Stereotaxis stock price today?▼
The current price of STXS is $1.42 USD — it has increased by +0% in the past 24 hours. Watch Stereotaxis stock price performance more closely on the chart.
What is Stereotaxis stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XASE exchange Stereotaxis stocks are traded under the ticker STXS.
Is Stereotaxis stock price growing?▼
STXS stock has risen by +4.41% compared to the previous week, the month change is a +10.08% rise, over the last year Stereotaxis has showed a -48.55% decrease.
What is Stereotaxis market cap?▼
Today Stereotaxis has the market capitalization of 142.29M
When is the next Stereotaxis earnings date?▼
Stereotaxis is going to release the next earnings report on November 05, 2026.
What were Stereotaxis earnings last quarter?▼
STXS earnings for the last quarter are -0.05 USD per share, whereas the estimation was -0.05 USD resulting in a +0% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Stereotaxis revenue for the last year?▼
Stereotaxis revenue for the last year amounts to 32.38M USD.
What is Stereotaxis net income for the last year?▼
STXS net income for the last year is -22.91M USD.
How many employees does Stereotaxis have?▼
As of August 25, 2026, the company has 131 employees.
In which sector is Stereotaxis located?▼
Stereotaxis operates in the Health & Wellness sector.
When did Stereotaxis complete a stock split?▼
The last stock split for Stereotaxis was on September 15, 2015 with a ratio of 5:4.
Where is Stereotaxis headquartered?▼
Stereotaxis is headquartered in ST.LOUIS, United States.